Not Signed In - Majority Of Anemic Chronic Kidney Disease Pre-Dialysis Patients Achieved Target Hemoglobin Range With PROCRIT® (Epoetin Alfa)
Thu, 23 Nov 2006 08:00 AM EST
... Today, at the American Society of Nephrology's 39th Annual Meeting and Scientific Exposition, data was presented for the first time on the initiation of PROCRIT® (Epoetin alfa) therapy 20,000 Units once every two weeks in patients with anemia related to chronic kidney disease (CKD) who are not on dialysis. [click link for full article] ...
Related Topics
- Dialysis
- Kidney Disease
- Kidney Diseases
- Chronic Diseases
- Hemoglobin
- Polycystic Kidney Disease
- Peritoneal Dialysis
- Epoetin Alfa
- Kidney Failure
- Anemia in Kidney Disease and Dialysis
- Kidney Cysts
- Hematocrit
- Kidney Failure and Dialysis
- Infection (kidney)
- Chronic Obstructive Pulmonary Disease
- Kidney Stones
- Lung Diseases & Disorders
- Diseases & Conditions
- Hemoglobin H Disease
- Kidney Dialysis
email this page
print this page
bookmark this page
feedback on this page
